Karyopharm Therapeutics KPTI
NASDAQ KPTI
$1.96 +0.14 (+7.69%)
At close: Aug 21, 2026 · 4:00 PM EDT

Karyopharm Therapeutics (KPTI) Tax Rate Growth (3y) (2020 - 2025)

Karyopharm Therapeutics (KPTI) Tax Rate Growth (3y) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Karyopharm Therapeutics 56.72 Mn 56.72 Mn 32.35 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -4,553.00
Sep 30, 2025 2.00
Jun 30, 2025 14.00
Mar 31, 2025 16.00
Dec 31, 2024 7.00
Sep 30, 2024 12.00
Jun 30, 2024 53.00
Mar 31, 2024 7.00
Dec 31, 2023 7.00
Sep 30, 2023 5.00
Jun 30, 2023 -9.00
Mar 31, 2023 -3.00
Dec 31, 2022 -26.00
Sep 30, 2022 -8.00
Jun 30, 2022 -23.00
Mar 31, 2022 -30.00
Dec 31, 2021 -28.00
Sep 30, 2021 -18.00
Jun 30, 2021 -30.00
Mar 31, 2021 -23.00